MH
Therapeutic Areas
OncoNano Medicine Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ONM-501 | Advanced solid tumors and lymphomas | Phase 1 |
Leadership Team at OncoNano Medicine
KK
Kartik Krishnan, MD, PhD
Chief Executive Officer
BS
Brent Sorrells
Chief Operating Officer
TZ
Tian Zhao, PhD
Vice President, Research and Development
RH
Ruolan Han, PhD
Vice President, Nonclinical and Translational Medicine
DH
Dean Hodgson
Vice President, Technical Operations
BP
Brett P. Giroir, MD
Chairman of the Board